Castle Biosciences Inc. (CSTL)

21.34

-0.34 (-1.57%)

At close: Mar 03, 2025, 3:59 PM

21.27

-0.33%

After-hours: Mar 03, 2025, 04:54 PM EST

Castle Biosciences Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	18.25M	-57.47M	-67.14M	-31.29M	-10.28M	5.28M	-6.37M	-12.37M
Depreciation & Amortization	16M	12.33M	10.54M	3.41M	472K	358K	323.02K	310.82K
Stock-Based Compensation	50.32M	51.22M	36.32M	21.74M	8.31M	1.25M	293.64K	108.7K
Other Working Capital	3.08M	6.55M	7.31M	384K	8.3M	738K	1.43M	-467.65K
Other Non-Cash Items	-6.97M	-4.86M	-19.5M	33.04M	823K	2.37M	542.37K	520.23K
Deferred Income Tax	1.4M	-223K	-1.88M	-8.74M	1.4M	-2.28M	272.42K	-163.29K
Change in Working Capital	-14.13M	-6.63M	-7K	-4.1M	9.15M	44K	-7.36M	-640.51K
Operating Cash Flow	64.87M	-5.63M	-41.66M	-18.98M	9.87M	7.01M	-12.29M	-12.23M
Capital Expenditures	-28.33M	-13.62M	-5.63M	-3.48M	-4.75M	-937K	-277.04K	-494.85K
Acquisitions	n/a	n/a	-26.97M	-63.18M	3K	n/a	n/a	n/a
Purchase of Investments	-205.73M	-189.07M	-134.69M	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	183.9M	186.5M	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	18K	13K	742K	10K	3K	n/a	n/a	n/a
Investing Cash Flow	-50.14M	-16.18M	-166.54M	-66.66M	-4.75M	-937K	-277.04K	-494.85K
Debt Repayment	9.9M	-142K	-122K	-8K	-27.36M	20.92M	5.42M	8.57M
Common Stock Repurchased	n/a	-5.13M	-1.69M	-781K	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-3.76M	-2.16M	1.64M	5.43M	3.21M	1.44M	10.38M	292.71K
Financial Cash Flow	6.14M	-2.3M	1.51M	5.42M	305.89M	88.29M	15.84M	8.87M
Net Cash Flow	20.87M	-24.11M	-206.69M	-80.22M	311.01M	94.37M	3.27M	-3.86M
Free Cash Flow	36.54M	-19.25M	-47.29M	-22.47M	5.11M	6.08M	-12.57M	-12.73M